JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on May 5, 2005; DOI: 10.1124/jpet.105.085944


0022-3565/05/3142-804-810$20.00
JPET 314:804-810, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.085944v1
jpet.105.085944v2
314/2/804    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shafaroudi, M. M.
Right arrow Articles by McGrath, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shafaroudi, M. M.
Right arrow Articles by McGrath, J. C.

CARDIOVASCULAR

Two "Knockout" Mouse Models Demonstrate That Aortic Vasodilatation Is Mediated via {alpha}2A-Adrenoceptors Located on the Endothelium

Majid Malekzadeh Shafaroudi1, Melissa McBride1, Clare Deighan, Alexis Wokoma, Joyce Macmillan, Craig J. Daly, and John C. McGrath

Autonomic Physiology Unit, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, Scotland (M.M., C.D., A.W., J.M., C.J.D., J.C.M.); and Sari Medical Faculty, Mazandaran, Iran (M.M.S.)

UK-14,304 [5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine]-mediated vasodilator responses were studied on wire myograph-mounted mouse aorta to determine the cells involved, mechanisms of action, and subtypes of {alpha}2-adrenoceptors. In the presence of induced tone, UK-14,304 produced concentration-related vasodilatation that was abolished by rauwolscine, N{omega}-nitro-L-arginine methyl ester (L-NAME), or endothelium removal, indicating that endothelial {alpha}2-adrenoceptors can release nitric oxide. In the {alpha}2A-adrenoceptor knockout mouse and the D79N mouse, a functional knockout of the {alpha}2A-adrenoceptor, these relaxant effects of UK-14,304 were lost, indicating the involvement of the {alpha}2A-adrenoceptor. UK-14,304 could also contract aorta: a small contraction occurred at high concentrations, was enhanced by L-NAME, and was absent in the {alpha}1D-adrenoceptor knockout mouse, indicating activation of the {alpha}1D-adrenoceptor. There was no evidence for a contractile {alpha}2-adrenoceptor-mediated response. A fluorescent ligand, quinazoline piperazine bodipy, antagonized the relaxant action of UK-14,304. This compound could be visualized on aortic endothelial cells, and its binding could be prevented by rauwolscine, providing direct evidence for the presence of {alpha}2-adrenoceptors on the endothelium. Norepinephrine reduced tone in the {alpha}1D-adrenoceptor knockout and controls, an effect blocked by rauwolscine and L-NAME but not by prazosin. This suggests that norepinephrine activates endothelial {alpha}2-adrenoceptors. In conclusion, the endothelium of mouse aorta has an {alpha}2A-adrenoceptor that responds to norepinephrine; promotes the release of nitric oxide, causing smooth muscle relaxation; and that can be directly visualized. Knockout or genetic malfunction of this receptor should increase arterial stiffness, exacerbated by raised catecholamines, and contribute to heart failure.


Received March 7, 2005; accepted May 3, 2005.

Address correspondence to: Professor J. C. McGrath, Autonomic Physiology Unit, Institute of Biomedical and Life Sciences, West Medical Bldg., University of Glasgow, Glasgow G12 8QQ, UK. E-mail: i.mcgrath{at}bio.gla.ac.uk




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. C. Duling, T. W. Cherng, J. R. Griego, M. F. Perrine, and N. L. Kanagy
Loss of {alpha}2B-adrenoceptors increases magnitude of hypertension following nitric oxide synthase inhibition
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2403 - H2408.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.